Hypoxia regulates GR function through multiple mechanisms involving microRNAs 103 and 107

Mol Cell Endocrinol. 2020 Dec 1:518:111007. doi: 10.1016/j.mce.2020.111007. Epub 2020 Aug 29.

Abstract

Glucocorticoids (Gcs) potently inhibit inflammation, and regulate liver energy metabolism, often acting in a hypoxic environment. We now show hypoxic conditions open a specific GR cistrome, and prevent access of GR to part of the normoxic GR cistrome. Motif analysis identified enrichment of KLF4 binding sites beneath those peaks of GR binding exclusive to normoxia, implicating KLF4 as a pioneer, or co-factor under these conditions. Hypoxia reduced KLF4 expression, however, knockdown of KLF4 did not impair GR recruitment. KLF4 is a known target of microRNAs 103 and 107, both of which are induced by hypoxia. Expression of mimics to either microRNA103, or microRNA107 inhibited GR transactivation of normoxic target genes, thereby replicating the hypoxic effect. Therefore, studies in hypoxia reveal that microRNAs 103 and 107 are potent regulators of GR function. We have now identified a new pathway linking hypoxia through microRNAs 103 and 107 to regulation of GR function.

Keywords: Glucocorticoid receptor; Glucocorticoids; HIF-1α; Hypoxia; MicroRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Hypoxia / physiology*
  • Dexamethasone / pharmacology
  • Gene Expression Regulation / drug effects
  • Glucocorticoids / pharmacology
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Hypoxia / genetics
  • Hypoxia / metabolism
  • Hypoxia / pathology
  • Kruppel-Like Factor 4
  • MicroRNAs / genetics
  • MicroRNAs / physiology*
  • Receptors, Glucocorticoid / physiology*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics

Substances

  • Glucocorticoids
  • KLF4 protein, human
  • Kruppel-Like Factor 4
  • MIRN103 microRNA, human
  • MIRN107 microRNA, human
  • MicroRNAs
  • Receptors, Glucocorticoid
  • Dexamethasone